Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

Yves Bertrand, Stefan Suciu, Nathalie Grardel, Marleen Bakkus, PhD, Francoise Mazingue, MD, Karima Yacouben, Anne Uyttebroeck, Patrick Lutz, Dominique Plantaz, Sandrine Girard, Nicole Dastugue, Yves Benoit, MD, Hélène Cavé

Blood (2011) 118 (21): 2571.

https://doi.org/10.1182/blood.V118.21.2571.2571

Published: 2011

Journal Articles

HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

Matthew M. Hsieh, N. Seth Linde, Aisha Wynter, Mark Metzger, Carol Wong, Ingrid Langsetmo, Al Lin, Reginald Smith, Griffin P. Rodgers, Robert E. Donahue, Stephen J. Klaus, John F. Tisdale

Blood (2007) 110 (6): 2140–2147.

https://doi.org/10.1182/blood-2007-02-073254

Published: 2007

Journal Articles

Early proliferation of CCR5 + CD38 +++ antigen-specific CD4 + Th1 effector cells during primary HIV-1 infection

John J. Zaunders, Mee Ling Munier, Daniel E. Kaufmann, Susanna Ip, Pat Grey, Don Smith, Tim Ramacciotti, Dick Quan, Robert Finlayson, John Kaldor, Eric S. Rosenberg, Bruce D. Walker, David A. Cooper, Anthony D. Kelleher, on behalf of the PHAEDRA Study Team

Blood (2005) 106 (5): 1660–1667.

https://doi.org/10.1182/blood-2005-01-0206

Published: 2005

Journal Articles

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Chrystèle Bilhou-Nabera, MD, PhD, Joris R. Andrieux, MD, PhD, Olivier Pierre-Louis, Marie-Caroline Le Bousse-Kerdilès, PhD, Brigitte Dupriez, MD, Nathalie Grardel, MD, Agnès Charpentier, MD, Vincent Praloran, MD, Francis Bauters, MD, Jean Luc Laï, PhD, Jean Loup Demory, MD

Blood (2004) 104 (11): 2436.

https://doi.org/10.1182/blood.V104.11.2436.2436

Published: 2004

Journal Articles

Preferential and persistent depletion of CCR5 + T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection

Roman Krzysiek, Annick Rudent, Laurence Bouchet-Delbos, Arnaud Foussat, Claudie Boutillon, Alain Portier, Didier Ingrand, Daniel Sereni, Pierre Galanaud, Liliane Grangeot-Keros, Dominique Emilie, the ANRS O86 PRIMOFERON A Study Group

Blood (2001) 98 (10): 3169–3171.

https://doi.org/10.1182/blood.V98.10.3169

Published: 2001

NARROW

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

Early proliferation of CCR5 + CD38 +++ antigen-specific CD4 + Th1 effector cells during primary HIV-1 infection

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Preferential and persistent depletion of CCR5 + T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection

Email alerts

ASH Publications

American Society of Hematology

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

Early proliferation of CCR5 + CD38 +++ antigen-specific CD4 + Th1 effector cells during primary HIV-1 infection

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Preferential and persistent depletion of CCR5 + T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only